carbostyril has been researched along with Female Genitourinary Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greub, G; Hammerschlag, MR; Senn, L | 1 |
| Berger, NS; Crawford, ED; Davis, MA; Donohue, RE | 1 |
1 review(s) available for carbostyril and Female Genitourinary Diseases
| Article | Year |
|---|---|
Therapeutic approaches to Chlamydia infections.
Topics: Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Conjunctivitis, Inclusion; Female Urogenital Diseases; Humans; Macrolides; Pneumonia, Bacterial; Practice Guidelines as Topic; Quinolones; Randomized Controlled Trials as Topic; Tetracyclines; Trachoma | 2005 |
1 trial(s) available for carbostyril and Female Genitourinary Diseases
| Article | Year |
|---|---|
Prevention of urinary tract infection and bacteremia following transurethral surgery: oral lomefloxacin compared to parenteral cefotaxime.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Bacteremia; Cefotaxime; Female; Female Urogenital Diseases; Fluoroquinolones; Humans; Injections; Male; Male Urogenital Diseases; Postoperative Complications; Premedication; Quinolones; Urethra; Urinary Tract Infections | 1992 |